The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Guide to Preventive Cardiology for Women
Open accessAbstract
C oronary heart disease (CHD) is the single leading cause of death and a significant cause of morbidity among American women. 1 Risk factors for CHD in women are well documented. 2 Compelling data from epidemiological studies and randomized clinical trials show that CHD is largely preventable.Assessment and management of several risk factors for CHD are cost-effective.3 Despite these facts, there are alarming trends in the prevalence and management of risk factors in women. 2 Smoking rates are declining less for women than for men.The prevalence of obesity is increasing, and Ϸ25% of women report no regular sustained physical activity.4 Approximately 52% of women Ͼ45 years old have elevated blood pressure, and Ϸ40% of women Ͼ55 years old have elevated serum cholesterol.5 The purpose of this statement is to highlight risk factor management strategies that are appropriate for women with a broad range of CHD risk.A more detailed description, including the scientific basis for these recommendations, is available in the 1997 American Heart Association scientific statement "Cardiovascular Disease in Women." 2 Recently, the Centers for Disease Control and Prevention National Ambulatory Medical Care Survey 6 showed clinicians are missing opportunities to prevent CHD.In this study of 29 273 routine office visits, women were counseled less often than men about exercise, nutrition, and weight reduction.In the multicenter Heart and Estrogen/progestin Replacement Study (HERS), 7 only 10% of women enrolled with documented CHD had baseline LDL-cholesterol levels below a National Cholesterol Education Program (NCEP) target of 100 mg/dL.A recent national survey showed that women were significantly less likely than men to enroll in cardiac rehabilitation after an acute myocardial infarction (MI) or bypass surgery.8 This finding is especially important because post-MI patients not enrolled in cardiac rehabilitation are less likely to receive aggressive risk factor management.Recommendations for the primary and secondary prevention of CHD have been published.9,10 Although those recommendations apply to women, there are aspects of risk factor management that are unique to women.Pregnancy and the preconception period are optimal times to review a woman's risk factor status and health behaviors to reduce future cardiovascular disease.Pregnant women should be strongly encouraged to discontinue smoking and not to relapse in the postpartum period.Avoidance of excess weight gain during pregnancy may reduce the risk of developing CHD in the future.An emphasis on prevention of CHD in postmenopausal women is particularly important because the incidence of CHD rises with age.The use of estrogen replacement therapy (ERT) to prevent CHD, osteoporosis, and possibly dementia is a difficult health decision for postmenopausal women.The potential benefits of therapy must be weighed against the possible risks, including breast cancer, gallbladder disease, thromboembolic disease, and endometrial cancer, although the last is reduced by concomitant use of a progestin.The recent findings from HERS 11 have challenged previous observational data regarding the role of hormones in preventing subsequent cardiovascular events.HERS was the first largescale, randomized, clinical trial in older postmenopausal women with confirmed coronary disease to test the efficacy and safety of hormone replacement therapy on clinical cardiovascular outcome in postmenopausal women.The study population included 2763 women (mean age 66.7 years) with established CHD randomly assigned to 0.625 mg conjugated equine estrogens (CEE) plus 2.5 mg of medroxyprogesterone acetate (MPA) per day or placebo.Participants were monitored for an average of 4.1 years for the main end point of nonfatal MI or CHD death.At study completion, no significant differences existed between groups for any cardiovascular end points.Surprisingly, after 1 year, HERS showed an increase in cardiovascular events in the treatment arm, but in years 4 and 5, fewer events occurred than in the placebo arm.It has been hypothesized that possible early adverse effects of estrogen in women with CHD may be due to a procoagulant effect that may later be offset by an antiatherogenic benefit.MPA may also have adverse cardiovascular effects and may mitigate some of the beneficial effects of estrogen.2 Although these hypotheses deserve further investigation, the overall null result from HERS does not support initiation of CEE combined with MPA in older postmenopausal women with confirmed coronary disease.For women with CHD already on ERT for Ն1 year, it may be reasonable to continue therapy while awaiting the results of a HERS follow-up study and other ongoing trials of ERT with clinical end points.The results of the HERS trial apply to women with preexisting CHD and may not apply to women free of vascular "A Guide to Preventive Cardiology for Women" was approved by the American College of Cardiology Board of Trustees on Feb
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Physical Activity and Health: A Report of the Surgeon General: (525162010-001)
(1995) · PsycEXTRA Dataset · doi:10.1037/e525162010-001 · Cited by 5,479
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Self-citationACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Gibbons, R. J., Balady, G. J., Beasley, J. W., FAAFP, Bricker, J. T., Duvernoy, W. F. C., Froelicher, V. F., Mark, D. B., Marwick, T. H., McCallister, B. D., et al. (1997) · Circulation · doi:10.1161/01.cir.96.1.345 · Cited by 1,094
Mosca, L., Manson, J. E., Sutherland, S. E., Langer, R. D., Manolio, T., & Barrett-Connor, E. (1997) · Circulation · doi:10.1161/01.cir.96.7.2468 · Cited by 736
Self-citation
Cited by
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
Self-citationPearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020190.45892.75 · Cited by 1,854
Self-citationEl Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., Allison, M. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000912 · Cited by 1,219
Self-citationEvidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., Grady, D., Haan, C. K., Hayes, S. N., Judelson, D. R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000114834.85476.81 · Cited by 917
Self-citationInsights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
Bairey Merz, C. N., Shaw, L. J., Reis, S. E., Bittner, V., Kelsey, S. F., Olson, M., Johnson, B. D., Pepine, C. J., Mankad, S., Sharaf, B. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.084 · Cited by 851
Metadata
- Authors
- Mosca, L., Grundy, S. M., Judelson, D., King, K., Limacher, M., Oparil, S., Pasternak, R., Pearson, T. A., Redberg, R. F., Smith, S. C., Winston, M., & Zinberg, S.
- Venue
- Circulation
- Published
- 1999-05-11
- Volume
- 99
- Issue
- 18
- Pages
- 2480-2484
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2059022881
- Cited by
- 380
- References
- 24
- FWCI
- 38.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guide to Preventive Cardiology for Women. https://app.cochat.ai/papers/10.1161/01.cir.99.18.2480
- The paper
- Mosca, L., Grundy, S. M., Judelson, D., King, K., Limacher, M., Oparil, S., Pasternak, R., Pearson, T. A., Redberg, R. F., Smith, S. C., Winston, M., & Zinberg, S. (1999). Guide to Preventive Cardiology for Women. Circulation. https://doi.org/10.1161/01.cir.99.18.2480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.